English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Microwave endometrial ablation at 2.45 GHz using a thin, curved microwave applicator for organic menorrhagia was developed more than 10 years ago. Since then, the number of patients who undergo this treatment has been gradually increasing. Additionally, various clinical applications of microwave ablation to gynecologic lesions, including direct microwave ablation therapy for myoma and adenomyosis, is occasionally conducted. Other techniques include transcervical microwave myolysis for uterine myomas and transcervical microwave adenomyolysis for uterine adenomyosis combined with microwave endometrial ablation. Necrosis followed by shrinkage of myomas and adenomyosis after microwave ablation therapy has been observed in a pilot study. Microwave endometrial ablation as an alternative to hysterectomy appears to be a logical choice for treating noninvasive endometrial cancer and atypical endometrial hyperplasia when the patient is a poor surgical candidate.

Application of Microwave Ablation at a Frequency of 2.45 GHz to the Uterus: Present and Future